January   | View Newsletter

February | View Newsletter

March | View Newsletter

Includes:

• Degarelix vs. Leuprolide in Advanced Prostate Cancer: Further Analysis of a Phase III Pivotal Trial

• Us TOO Names New Board Reps for 2010

• Dendreon Receives FDA Acknowledgement of Complete Response for Provenge BLA Resubmission

• Doc Moyad’s “No Bogus Science” Column—Statins & Low Cholesterol “Hit Another Home Run”

• Drug Eases ADT Side Effect in Men

• PSA Screening Should Be Offered to Older Men

• Read more..

Includes:

• ERSPC Study Shows PSA Screening Reduced Prostate Cancer Deaths by 20 Percent

• PSA Velocity May Help Identify Insignificant Prostate Cancer

• NCCN Prostate Cancer Guidelines Stress Careful Consideration of Active Surveillance

• An Update of the Gleason Grading System

• Coffee May Cut Risk of Prostate Cancer

• Radiofrequency Ablation Safe and Effective for Reducing Pain from Bone Metastases

• Ask Dr. Snuffy Myers

• Read more..

Includes:

• Public-Private Divide in Prostate Cancer Treatment

• Exercise May Prevent Incontinence from Prostate Cancer Surgery

• Similar Effectiveness among Management Options for Low-Risk Prostate Cancer

• Soy May Protect Against Prostate Cancer

• ZERO’s ―Prostate Polar Plunge

• Ask Dr. Snuffy Myers

• Alternative Prostate Cancer Vaccine Shows Promise

• Frequent Sex and Masturbation in 20s and 30s Linked to Higher Prostate Cancer Risk

• Read more..

April | View Newsletter

MAY | View Newsletter

June | View Newsletter

Includes:

• New Prostate Cancer Screening Guidelines – Commentary by Dr. Len Lichtenfeld

• AUA Responds to Updated ACS Guidelines

• Complex New Guidelines from Multiple Organizations Confuse Men about Prostate Cancer Screening

• American Cancer Society – Ignorance is Bliss When it Comes to Prostate Cancer

• Which Men Should Take Finasteride?

• Robot-Assisted Surgery Is no Better Treatment for Prostate Cancer

• American Cancer Society Updates Guidelines

• Doc Moyad’s “No Bogus Science” Column – Weight Loss Supplements Are a Problem So Be Careful

• Read more..

Includes:

• ASCO Statement on the Passage of the Patient Protection & Affordable Health Care Act

• A Treatment for Prostate Cancer “Inadequate” Half the Time

• Positive Results for Sanofi-Aventis Drug

• PSA & the PSA Test: What the Public Needs to Know

• Infertility & Prostate Cancer May Have a Common Cause

• Ask Dr. Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – L-Theanine Anti-Stress Amino Acid Found in Tea

• Doctor Chodak’s Bottom Line

• Read more..

Includes:

• FDA Approves Prostate Cancer Vaccine

• Active Surveillance May Not Be Best Option

• MDV3100 Shows “Substantial Activity” in Advanced Prostate Cancer

• Radiation for Prostate Cancer Lacks Data

• Discussing Provenge with Cancer Patients^®

• Prostate Cancer Progresses More Quickly in African-American Men

• Ask Dr. Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – Provenge^® Receives FDA Approval

• FDA Scrutiny of GnRH Agonists Continues

• Degarelix Shows Promise as Second-Line Hormonal Therapy for Prostate Cancer Patients

• Read more..

July | View Newsletter

August | View Newsletter

September | View Newsletter

Includes:

• RT Shown Beneficial for Prostate Cancer Subset

• Denosumab Extends Time to Bone Events

• Us TOO Seeks Board Member Applications

• High-Intensity Focused Ultrasound (HIFU) Non-Inferior to EBRT for Prostate Cancer

• Cabazitaxel Benefit Confirmed in Prostate Cancer Now FDA Approved (Jevtana^®, sanofi-aventis)

• Doc Moyad’s “No Bogus Science” Column – “Exercise Ups Cialis^®, Levitra^® & Viagra^®”

• Pelvic RT Increases Hip Fracture Risk in Men

• Bevacizumab (Avastin^®) Fails to Prolong Survival in Resistant Prostate Cancer

• PSA Misses the Mark in Active Surveillance

• Read more..

Includes:

• Medicare to Review Provenge® Coverage

• Patients Face Yearlong Rationing of Provenge

• Leather Wristbands Help Raise Awareness, Prostate Cancer Funds

• PSA Test Does Cut Prostate Cancer Deaths

• Cabazitaxel (Jevtana®) New Chemotherapy Approved for Advanced Prostate Cancer

• Doc Moyad’s “No Bogus Science” Column – “Too Much Vitamin D3 Is Not a Good Thing”

• Ask Doctor Snuffy Myers

• Seeking Patients for New Study to Improve Prediction of Prostate Biopsy Results

• Statins Reduce PSA Spikes After Surgery

• Read more..

Includes:

• Immunotherapy Benefits Prostate Cancer

• Bone Density May Predict Prostate Cancer

• Dendreon’s $93K Price Must Be Paid by US

• PSA Screening Can Lead to Overtreatment

• PAF Announces Additional Support for Co-Pay Relief Program for Prostate Cancer

• Doc Moyad’s “No Bogus Science” Column – “Too Much Folic Acid May Not Be Good”

• Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

• Ask Doctor Snuffy Myers

• Stand Up to Cancer Is Back

• Five New Genetic Variations Linked to Prostate Cancer in Study on Japanese Men

• Read more..

October  | View Newsletter

November | View Newsletter

December | View Newsletter

Includes:

• Oct 13 Webinar: Understanding Diagnostic Testing for Prostate Cancer Patients

• Comorbidities May Be Key in Prostate Cancer Treatment Decisions

• What Are Men Being Told About Their Treatment Options for Prostate Cancer

• My Prostate Cancer Roadmap – Resource for Men with Advanced Prostate Cancer

• Summary of Us TOO’s Summit, Symposium and 20th Anniversary Celebration

• Abiraterone Acetate Study Unblinded after Meeting Pre-Determined Criteria

• Ask Doctor Snuffy Myers

• Doctor Chodak’s Bottom Line

• Doc Moyad’s “No Bogus Science” Column – “Let’s Walk the Talk This Month!”

• Prostate Biopsy Can Cause Urinary and Erectile Problems

• Read more..

Includes:

• Us TOO Board Welcomes 2 New Members

• Risk Factors for Prostate Cancer Differ Between Native and Foreign Born Black Men

• Cabazitaxel – New Approach for Prostate Cancer

• Protein Array Accurate for Prostate CA

• AstraZeneca Drug Fails vs. Prostate Cancer

• No Prostate Cancer Indication for Sunitinib

• Us TOO Seeking Nominations for Kaps Award

• Teva Launches Prostate Cancer Phase III Study

• Comparing Radiation Treatments

• POM Wonderful vs. Federal Trade Commission

• Us TOO Seeks Board Member Applications

• Read more..

Includes:

• Holiday Giving? Remember Us TOO

• Drug Extends Survival in Prostate Cancer

• Cost Should Enter Effectiveness Equation

• Atypical Prostate Biopsy Should Be Repeated

• Calypso Dynamic Edge Gating Technology Receives FDA 510(k) Clearance

• PSA Test Reduces Risk of Spread if Prostate Cancer Strikes

• VA Begins Paying Benefits for New Agent Orange Exposure

• New Warnings on Prostate Cancer Drugs

• Aspirin Associated with Reduced Risk of Prostate Cancer Death

• Doc Moyad’s “No Bogus Science” Column – “Mega-Dose Vitamins”

• Ask Doctor Snuffy Myers

• Doctor Chodak’s Bottom Line

• Read more..